Canopy Growth Total Assets 2018-2025 | CGC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Canopy Growth total assets from 2018 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Canopy Growth total assets from 2018 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.2B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$149.2B
EssilorLuxottica (ESLOY)	$131.9B
Medtronic (MDT)	$115.1B
Lonza Group Ag (LZAGY)	$50.1B
Haleon (HLN)	$43.5B
ResMed (RMD)	$37.3B
GE HealthCare Technologies (GEHC)	$34.5B
Agilent Technologies (A)	$32.2B
Terumo (TRUMY)	$24.4B
Koninklijke Philips (PHG)	$23.5B
Insulet (PODD)	$20.3B
Zimmer Biomet Holdings (ZBH)	$18.6B
Baxter (BAX)	$14.6B
Smith & Nephew SNATS (SNN)	$13B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$5.1B
Perrigo (PRGO)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.7B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.9B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B